Mexico: Baker McKenzie wins important litigation precedents over the renewal of marketing authorizations for drugs and medical devices

In brief

The firm successfully asserted that, a failure to submit on time an application to renew a marketing authorization (MA), for a drug or medical device, does not change the legal possibility to have such application approved tacitly.

In both cases, the courts ordered the Federal Commission for the Protection against Sanitary Risks ("COFEPRIS") to grant the renewal of the MA.


Contents

What it means for you?

If your company lost a MA because the renewal application was not filed on time, but the health regulator did not meet legal deadlines either, we can help you recover that MA.

In more detail

Many healthcare companies, for different reasons, failed to submit on time some applications to renew MAs, particularly during the pandemic. In those cases, eventually, COFEPRIS: (i) rejected the renewal applications and (ii) cancelled the original MAs. This had a significant commercial impact.

Noteworthy, at the same time:

  1. This federal administration has experienced huge regulatory delays, failing constantly to meet applicable legal deadlines.
  2. Around half of the time, when the specialized health regulation foresees the need to obtain an authorization*, it introduces also a positive legal rule, thanks to which, if the authority fails to take a decision within the applicable legal deadline, the application for all legal purposes "shall be considered approved". The renewal of MAs is one of those cases.

In the cases we won, the courts ordered COFEPRIS to grant the renewal, even if the MA renewal application was filed extemporaneously.

These are important precedents because they change prior understandings that were common in the industry, which considered that nothing could be done, once a cancellation had occurred in the circumstances described above.

For further information and individual assistance regarding this new opportunity, please get in touch with our experts.


* Lopez-Silva C. The afirmativa ficta as a regulatory tool in health regulation. In Health Law: An integral perspective. Tirant Lo Blanch. 2022.


Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.